CYPA.US Cyphaira Corp.

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
1.45 USD
Close of Nov 7, 2026
1.18 1.46
Market cap
USD 46.6M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is CYPA.US undervalued?

Graham number

The Graham number of Cyphaira Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cyphaira Corp. fundamental analysis

No fundamental analysis for Cyphaira Corp. yet.

Cyphaira Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cyphaira Corp.

Cyphaira Corp. provides decision-intelligence software services in the United States. The company offers SolvixLMS, an operating system for regulated manufacturing environments, production, compliance state, process lineage, cost, and yield in one connected system. The company was formerly known as Growth Stalk Holdings Corp. and changed its name to Cyphaira Corp. in September 2026. Cyphaira Corp. was incorporated in 2021 and is based in Seminole, Oklahoma.

Full company profile